1. Home
  2. HTCR vs IMNN Comparison

HTCR vs IMNN Comparison

Compare HTCR & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$0.33

Market Cap

11.7M

Sector

Technology

ML Signal

N/A

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$3.17

Market Cap

12.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
IMNN
Founded
2009
1982
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
12.9M
IPO Year
2022
1985

Fundamental Metrics

Financial Performance
Metric
HTCR
IMNN
Price
$0.33
$3.17
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$182.61
AVG Volume (30 Days)
197.6K
34.8K
Earning Date
11-18-2025
11-13-2025
Dividend Yield
41.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,189,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$3.55
52 Week High
$3.38
$41.22

Technical Indicators

Market Signals
Indicator
HTCR
IMNN
Relative Strength Index (RSI) 31.80 26.75
Support Level $0.31 $3.80
Resistance Level $0.38 $4.00
Average True Range (ATR) 0.04 0.22
MACD 0.00 -0.04
Stochastic Oscillator 46.22 9.93

Price Performance

Historical Comparison
HTCR
IMNN

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: